PRISMASOL BGK4/0/1.2 is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Dextrose Monohydrate; Lactic Acid, Unspecified Form; Magnesium Chloride; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride.
Product ID | 24571-114_250f27ad-a700-4fd7-aaeb-7ca4211c17d8 |
NDC | 24571-114 |
Product Type | Human Prescription Drug |
Proprietary Name | PRISMASOL BGK4/0/1.2 |
Generic Name | Magnesium Chloride, Dextrose Monohydrate, Lactic Acid, Sodium Chloride, Sodium Bicarbonate And Potassium Chloride |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2006-10-25 |
Marketing Category | NDA / NDA |
Application Number | NDA021703 |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DEXTROSE MONOHYDRATE; LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
Active Ingredient Strength | 22 g/L; g/L; g/L; g/L; g/L; g/L |
Pharm Classes | Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2008-10-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021703 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-10-10 |
Marketing Category | NDA |
Application Number | NDA021703 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-10-10 |
Marketing End Date | 2017-12-31 |
Ingredient | Strength |
---|---|
MAGNESIUM CHLORIDE | 2.44 g/L |
SPL SET ID: | 7f675fee-8940-4ece-bb0c-75ac79d8708c |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
24571-102 | PRISMASOL | magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride |
24571-111 | PRISMASOL | magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride |
24571-114 | PRISMASOL | magnesium chloride, dextrose monohydrate, lactic acid, sodium chloride, sodium bicarbonate and potassium chloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRISMASOL 78601301 3341085 Live/Registered |
Gambro Lundia AB 2005-04-04 |
PRISMASOL 78032982 not registered Dead/Abandoned |
Gambro, Inc. 2000-10-30 |